GlassScriptPhysician profile
Sara Patry
NPI 1679955363
$5,248.30
in general payments reported to CMS, 2019-2025
38 companies · $852 in 2025
The $852 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2021: $13.31 · 2022: $833 · 2023: $1,668 · 2024: $1,552 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,072.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $892.48 | 2019-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $822.08 | 2021-2024 | |
| Amgen INC. | $800.04 | 2019-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $515.38 | 2019-2025 | |
| Lilly USA, LLC | $406.40 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $254.26 | 2022-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $134.90 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $116.67 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $108.64 | 2022-2025 | |
| Daiichi Sankyo INC. | $95.55 | 2022-2024 | Injectafer |
| Xeris Pharmaceuticals, INC. | $88.09 | 2022-2023 | Keveyis |
| Nestle Healthcare Nutrition INC. | $85.38 | 2022 | |
| Merck Sharp & Dohme LLC | $80.54 | 2022-2024 | Gardasil 9, Capvaxive, Gardasil |
| Abbott Laboratories | $76.67 | 2022-2024 | Freestyle Libre 3 |
| Abiomed | $73.78 | 2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.07 | 2022-2024 | Jardiance, Tradjenta, Synjardy |
| Exact Sciences Corporation | $60.48 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $45.01 | 2023-2025 | |
| Idorsia Pharmaceuticals US INC | $43.92 | 2023-2025 | Quviviq, Quviviq |
| Inspire Medical Systems, INC. | $40.29 | 2024-2025 | Inspire |
| Phathom Pharmaceuticals, INC. | $36.23 | 2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $33.50 | 2025 | Rexulti |
| Sunovion Pharmaceuticals INC. | $33.42 | 2022 | |
| Corium, LLC | $32.72 | 2022-2023 | Adlarity |
| Axsome Therapeutics, INC. | $32.62 | 2024 | Auvelity |
| Astrazeneca Pharmaceuticals LP | $31.56 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $31.07 | 2019-2022 | |
| Glaxosmithkline, LLC. | $28.48 | 2019-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $25.76 | 2022-2023 | Xarelto |
| Biohaven Pharmaceutical Holding Company LTD. | $23.46 | 2022 | |
| Insulet Corporation | $19.34 | 2023 | Omnipod |
| Mylan Specialty L.P. | $17.12 | 2024 | Yupelri |
| Radius Health, INC. | $16.60 | 2025 | Tymlos |
| Ucb, INC. | $16.24 | 2025 | Rystiggo |
| Actelion Pharmaceuticals US, INC. | $16.13 | 2025 | Uptravi, Opsumit |
| Astellas Pharma US INC | $15.98 | 2025 | Veozah |
| Strongbridge US INC. | $14.55 | 2019 | |
| Electromed, INC. | $12.89 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Patry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.